In This Issue
Special Series: XYZ of Statistics
Special Series: Big Science, Artificial Intelligence, and Machine Learning
Controversies in Nephrology
Point: Does metformin do more benefit or harm in chronic kidney disease patients? YES
Counterpoint: Metformin in chronic kidney disease: a strong dose of caution CON
From the Editors: Metformin—to use or not to use . . . is that the question?
2020 Cited articles
Kidney International (KI) is the official journal of the International Society of Nephrology. Under the editorial leadership of Dr. Pierre Ronco (Paris, France), KI is one of the most cited journals in nephrology and widely regarded as the world's premier journal on the development and consequences of kidney disease.
KI is peer-reviewed and publishes original research in both basic science and clinical medicine. These include the latest clinical studies on emerging developments in renal medicine and the highest level of original research studies in therapy and epidemiology of acute and chronic kidney failure, as well as their translational aspects and genetic basis. In addition relevant aspects of renal physiology, cell biology, biochemistry, pathology, immunology, morphology and new technological developments are reported with the over-all aim of informing the renal researcher and the practicing nephrologist on all aspects of renal research.
The journal reflects the field through critical reviews and original articles, commentaries, editorial updates on recent developments and news features, recommendations and guidelines resulting from expert consensus meetings, aspects of nephrology from the developing world, policy issues, remarkable images, and problem-focused articles for the diagnosis and treatment of renal patients. Kidney International is published monthly.
About the International Society of Nephrology
Advancing kidney health worldwide. Together.
The International Society of Nephrology (ISN) is a global professional association dedicated to advancing kidney health worldwide since 1960 through education, grants, research, and advocacy.
The ISN, through its members and in collaboration with national and regional societies, engages 30,000 health professionals from across the globe to reduce the burden of kidney diseases and provide optimal health care for patients.
KI on the Academy
This new online educational iniative features select KI and KI Reports authors presenting short video abstracts to introduce their published articles. Brought to you by the ISN Academy and ISN Education. View the video abstracts here.